Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jintiange capsule vs glucosamine sulfate in knee osteoarthritis
ChiCTR2300078371Phase 4Not yet recruiting
- Sponsor
- Zibo City Central Hospital
- Start
- Jan 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of jintiange in knee osteoarthritis (OA) (2 arms), sponsored by Zibo City Central Hospital. Primary endpoints: WOMAC score at week 24 and SF-36 score at week 24. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
jintiange
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300078371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078371.